167 related articles for article (PubMed ID: 15714210)
21. Cumulative probability of false-positive recall or biopsy recommendation after 10 years of screening mammography: a cohort study.
Hubbard RA; Kerlikowske K; Flowers CI; Yankaskas BC; Zhu W; Miglioretti DL
Ann Intern Med; 2011 Oct; 155(8):481-92. PubMed ID: 22007042
[TBL] [Abstract][Full Text] [Related]
22. Natural history of breast cancers detected in the Swedish mammography screening programme: a cohort study.
Zahl PH; Gøtzsche PC; Mæhlen J
Lancet Oncol; 2011 Nov; 12(12):1118-24. PubMed ID: 21996169
[TBL] [Abstract][Full Text] [Related]
23. Benefits and harms of annual, biennial, or triennial breast cancer mammography screening for women at average risk of breast cancer: a systematic review for the European Commission Initiative on Breast Cancer (ECIBC).
Canelo-Aybar C; Posso M; Montero N; Solà I; Saz-Parkinson Z; Duffy SW; Follmann M; Gräwingholt A; Giorgi Rossi P; Alonso-Coello P
Br J Cancer; 2022 Mar; 126(4):673-688. PubMed ID: 34837076
[TBL] [Abstract][Full Text] [Related]
24. Mammography screening: a new estimate of number needed to screen to prevent one breast cancer death.
Hendrick RE; Helvie MA
AJR Am J Roentgenol; 2012 Mar; 198(3):723-8. PubMed ID: 22358016
[TBL] [Abstract][Full Text] [Related]
25. Canadian National Breast Screening Study: 2. Breast cancer detection and death rates among women aged 50 to 59 years.
Miller AB; Baines CJ; To T; Wall C
CMAJ; 1992 Nov; 147(10):1477-88. PubMed ID: 1423088
[TBL] [Abstract][Full Text] [Related]
26. Integration of 3D digital mammography with tomosynthesis for population breast-cancer screening (STORM): a prospective comparison study.
Ciatto S; Houssami N; Bernardi D; Caumo F; Pellegrini M; Brunelli S; Tuttobene P; Bricolo P; Fantò C; Valentini M; Montemezzi S; Macaskill P
Lancet Oncol; 2013 Jun; 14(7):583-9. PubMed ID: 23623721
[TBL] [Abstract][Full Text] [Related]
27. Collaborative Modeling of the Benefits and Harms Associated With Different U.S. Breast Cancer Screening Strategies.
Mandelblatt JS; Stout NK; Schechter CB; van den Broek JJ; Miglioretti DL; Krapcho M; Trentham-Dietz A; Munoz D; Lee SJ; Berry DA; van Ravesteyn NT; Alagoz O; Kerlikowske K; Tosteson AN; Near AM; Hoeffken A; Chang Y; Heijnsdijk EA; Chisholm G; Huang X; Huang H; Ergun MA; Gangnon R; Sprague BL; Plevritis S; Feuer E; de Koning HJ; Cronin KA
Ann Intern Med; 2016 Feb; 164(4):215-25. PubMed ID: 26756606
[TBL] [Abstract][Full Text] [Related]
28. Comparison of Mortality Among Participants of Women's Health Initiative Trials With Screening-Detected Breast Cancers vs Interval Breast Cancers.
Irvin VL; Zhang Z; Simon MS; Chlebowski RT; Luoh SW; Shadyab AH; Krok-Schoen JL; Tabung FK; Qi L; Stefanick ML; Schedin P; Jindal S
JAMA Netw Open; 2020 Jun; 3(6):e207227. PubMed ID: 32602908
[TBL] [Abstract][Full Text] [Related]
29. Estimated Mortality of Breast Cancer Patients Based on Stage at Diagnosis and National Screening Guideline Categorization.
Patel SB
J Am Coll Radiol; 2018 Sep; 15(9):1206-1213. PubMed ID: 29793836
[TBL] [Abstract][Full Text] [Related]
30. Interval breast cancers in the Screening Mammography Program of British Columbia: analysis and classification.
Burhenne HJ; Burhenne LW; Goldberg F; Hislop TG; Worth AJ; Rebbeck PM; Kan L
AJR Am J Roentgenol; 1994 May; 162(5):1067-71; discussion 1072-5. PubMed ID: 8165983
[TBL] [Abstract][Full Text] [Related]
31. Early evaluation of an organised mammography screening program in Greece 2004-2009.
Simou E; Tsimitselis D; Tsopanlioti M; Anastasakis I; Papatheodorou D; Kourlaba G; Gerasimos P; Maniadakis N
Cancer Epidemiol; 2011 Aug; 35(4):375-80. PubMed ID: 21474412
[TBL] [Abstract][Full Text] [Related]
32. Comparison of breast cancers detected in the Verona screening program following transition to digital breast tomosynthesis screening with cancers detected at digital mammography screening.
Caumo F; Romanucci G; Hunter K; Zorzi M; Brunelli S; Macaskill P; Houssami N
Breast Cancer Res Treat; 2018 Jul; 170(2):391-397. PubMed ID: 29557996
[TBL] [Abstract][Full Text] [Related]
33. Screening Mammography for Women in Their 40s: The Potential Impact of the American Cancer Society and U.S. Preventive Services Task Force Breast Cancer Screening Recommendations.
Pitman JA; McGinty GB; Soman RR; Drotman MB; Reichman MB; Arleo EK
AJR Am J Roentgenol; 2017 Sep; 209(3):697-702. PubMed ID: 28504572
[TBL] [Abstract][Full Text] [Related]
34. Risk factors for second screen-detected or interval breast cancers in women with a personal history of breast cancer participating in mammography screening.
Houssami N; Abraham LA; Kerlikowske K; Buist DS; Irwig L; Lee J; Miglioretti DL
Cancer Epidemiol Biomarkers Prev; 2013 May; 22(5):946-61. PubMed ID: 23513042
[TBL] [Abstract][Full Text] [Related]
35. Effectiveness of and overdiagnosis from mammography screening in the Netherlands: population based study.
Autier P; Boniol M; Koechlin A; Pizot C; Boniol M
BMJ; 2017 Dec; 359():j5224. PubMed ID: 29208760
[No Abstract] [Full Text] [Related]
36. Annual mammography at age 45-49 years and biennial mammography at age 50-69 years: comparing performance measures in an organised screening setting.
Bucchi L; Ravaioli A; Baldacchini F; Giuliani O; Mancini S; Vattiato R; Falcini F; Giorgi Rossi P; Campari C; Canuti D; Di Felice E; Sassoli de Bianchi P; Ferretti S; Bertozzi N;
Eur Radiol; 2019 Oct; 29(10):5517-5527. PubMed ID: 30887204
[TBL] [Abstract][Full Text] [Related]
37. Clinical outcomes of modelling mammography screening strategies.
Yaffe MJ; Mittmann N; Lee P; Tosteson AN; Trentham-Dietz A; Alagoz O; Stout NK
Health Rep; 2015 Dec; 26(12):9-15. PubMed ID: 26676234
[TBL] [Abstract][Full Text] [Related]
38. Breast screening using 2D-mammography or integrating digital breast tomosynthesis (3D-mammography) for single-reading or double-reading--evidence to guide future screening strategies.
Houssami N; Macaskill P; Bernardi D; Caumo F; Pellegrini M; Brunelli S; Tuttobene P; Bricolo P; Fantò C; Valentini M; Ciatto S
Eur J Cancer; 2014 Jul; 50(10):1799-1807. PubMed ID: 24746887
[TBL] [Abstract][Full Text] [Related]
39. Survival and Disease-Free Survival by Breast Density and Phenotype in Interval Breast Cancers.
Sala M; Domingo L; Louro J; Torá-Rocamora I; Baré M; Ferrer J; Carmona-Garcia MC; Barata T; Román M; Macià F; Castells X;
Cancer Epidemiol Biomarkers Prev; 2018 Aug; 27(8):908-916. PubMed ID: 29853482
[No Abstract] [Full Text] [Related]
40. Comparison of digital screening mammography and screen-film mammography in the early detection of clinically relevant cancers: a multicenter study.
Bluekens AM; Holland R; Karssemeijer N; Broeders MJ; den Heeten GJ
Radiology; 2012 Dec; 265(3):707-14. PubMed ID: 23033499
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
